Jetrab D 30mg/20mg Tablet SR is a combination pharmaceutical formulation containing Domperidone 30mg and Rabeprazole 20mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and discomfort associated with delayed gastric emptying or gastroparesis. Rabeprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release (SR) formulation ensures a prolonged therapeutic effect, enhancing patient compliance by reducing dosing frequency. Jetrab D is indicated for patients requiring both prokinetic and acid-suppressive therapy to manage symptoms of acid reflux accompanied by delayed gastric emptying. It should be administered under medical supervision, with caution in patients with known hypersensitivity to either component, and avoided in those with underlying cardiac arrhythmias or significant hepatic impairment. Monitoring for potential side effects such as headache, dry mouth, or gastrointestinal disturbances is recommended during therapy.